How Eli Lilly’s Investors Cashed In 90% Capital Gains While Sales Barely Moved?
- Thursday, May 21, 2020, 7:10
- Market
- Add a comment
Eli Lilly’s stock moved nearly 90% between 2016 and 2019 even though the company barely had any revenue growth to show for it. So what got Eli Lilly’s investors excited? Its P/E ratio actually shrank 45% which is hardly a proof of investor exuberance! However, EPS expanded a massive 245%…
About the Author
admin123 has written 23527 stories on this site.
